Security key
74017N105
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 60,552,257
- Total 13F value
- $85,976,957
- Share change
- +3,161,690
- Put/Call ratio
- 23%
- SEC-reported price per share
- $1.42
- Number of holders
- 135
- Value change
- +$4,927,378
- Number of buys
- 53
- Number of sells
- 50
- Shares outstanding
- 353,007,843
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
135
Top holders
10
PGEN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
PRECIGEN, INC. SEC filings
PRECIGEN, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74017N105
Recent filing periods:
Ownership snapshot
Top reported holders of PGEN - PRECIGEN, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ares Trading S.A.
Disclosed value leader
Ares Trading S.A.
Comparable rows
0/15
Latest evidence
30 Jun 2023
3/4/5
13F
Highest disclosed value: $29,112,484
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Ares Trading S.A. has the largest disclosed position value at $29.11M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ares Trading S.A.'s linked filing trail.
Disclosed position value
Top 5
Ares Trading S.A.
$29.11M
Patient Capital Management, LLC
$12.93M
BlackRock Finance, Inc.
$11.92M
VANGUARD GROUP INC
$7.84M
IRIDIAN ASSET MANAGEMENT LLC/CT
$3.83M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ares Trading S.A. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$29,112,484
20,647,152 shares
|
— | 12 Oct 2021 |
| Patient Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$12,930,093
11,243,560 shares
|
— | 30 Jun 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$11,921,641
10,366,644 shares
|
— | 30 Jun 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$7,843,970
6,820,844 shares
|
— | 30 Jun 2023 |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
Company
|
—
denominator unverified
|
$3,833,488
3,333,468 shares
|
— | 30 Jun 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$3,307,618
2,876,190 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
135
Shares
60,552,257
Rows available
135
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
137
Q3 2023 holders
135
Holder diff
-2
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend